(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it has appointed Mark O. Thornton, M.D., Ph.D., Executive Vice President and Chief Development Officer. In this position, Dr. Thornton will be responsible for the oversight of all disciplines involved in the product development process and will report to the Chief Executive Officer and Chief Medical Officer, Jonathan Lewis, M.D., Ph.D. Dr. Thornton is rejoining ZIOPHARM Oncology, having previously served as the Company’s Chief Medical Officer & Head of Product Development and after having served as Medical Officer at the Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER).
